FDA Approves Luspatercept to Treat Anemia in Patients with Lower-Risk MDS
April 06, 2020
ByKristie L. Kahl

The FDA approved the first and only erythroid maturation agent for the treatment of anemia in patients with lower-risk myelodysplastic syndromes.

FDA Approves Luspatercept to Treat Beta Thalassemia–Associated Anemia
November 08, 2019
ByKristie L. Kahl

The agency approved the first and only FDA-approved erythroid maturation agent to treat anemia in adult patients with beta thalassemia who require regular red blood cell transfusions.

Researchers Make Anemia Discovery That May Provide New Targets for Therapy
February 05, 2018
ByJohn Schieszer

A new study has revealed that the amount of iron in the blood affects the amount of the Scribble protein, which appears to control receptors that create new red blood cells.